129 related articles for article (PubMed ID: 36709133)
1. [The establishment and multicenter application of internal quality control system for real-time quantitative PCR detection of BCR-ABL (P210) transcript level].
He N; Gu CY; Li QP; Zhou H; Chu LN; Ma DX
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):562-567. PubMed ID: 36709133
[No Abstract] [Full Text] [Related]
2. [The establishment and application of internal quality control system for real-time quantitative PCR detection of BCR-ABL (P210) transcript levels].
Zhong CQ; He N; Hua MQ; Wei XD; Ma DX; Ji CY
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):800-806. PubMed ID: 27719725
[TBL] [Abstract][Full Text] [Related]
3. [A multicenter comparison study on the quantitative detection of bcr-abl (P210) transcript levels in China].
Qin YZ; Cheng H; Cen JN; Geng SX; Li QH; Li XQ; Lin ZX; Ma DX; Qiao C; Wang YG; Li JL; Li LD; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):104-8. PubMed ID: 23611214
[TBL] [Abstract][Full Text] [Related]
4. [The influence of peripheral blood sample storage and delivery on the quantitative detection result of BCR-ABL (P210) transcript levels].
Hua MQ; He N; Zhong CQ; Yang XY; Liu JT; Wang RQ; Han FJ; Zhang C; Ma DX
Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):224-229. PubMed ID: 33910308
[No Abstract] [Full Text] [Related]
5. [A multicenter study on the validation of conversion factor for the conversion of BCR-ABL (P210) transcript levels to the international scale in chronic myeloid leukemia].
Qin Y; Lin Z; Cen J; Li X; Li Q; Cheng H; Geng S; Wang Y; Ma D; Qiao C; Li J; Li L; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):134-7. PubMed ID: 24606655
[TBL] [Abstract][Full Text] [Related]
6. Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression.
Wang WJ; Zheng CF; Liu Z; Tan YH; Chen XH; Zhao BL; Li GX; Xu ZF; Ren FG; Zhang YF; Chang JM; Wang HW
Eur J Haematol; 2018 Sep; 101(3):291-296. PubMed ID: 29691899
[TBL] [Abstract][Full Text] [Related]
7. Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Arocho A; Chen B; Ladanyi M; Pan Q
Diagn Mol Pathol; 2006 Mar; 15(1):56-61. PubMed ID: 16531770
[TBL] [Abstract][Full Text] [Related]
8. Use of the «BCR/ABL - multitest» kit in the algorithm of laboratory diagnostics of oncohematological diseases: economic aspects.
Gorbenko AS; Stolyar MA; Vasiliev EV; Mikhalev MA; Bakhtina VI; Olkhovik TI; Mochalova EE; Orlova KE; Olkhovskiy IA
Klin Lab Diagn; 2021 Sep; 66(9):571-576. PubMed ID: 34543537
[TBL] [Abstract][Full Text] [Related]
9. External quality assessment of p210 BCR-ABL1 transcript quantification by RT-qPCR: Findings and recommendations.
Fu Y; Zhang R; Wu Q; Zhang J; Bao L; Li J
Int J Lab Hematol; 2019 Feb; 41(1):46-54. PubMed ID: 30203581
[TBL] [Abstract][Full Text] [Related]
10. One-step discrimination of BCR/ABL
Luo N; Xia Q; Zhang L; Zhang Y; Huang L; Zhang Y; Zhao J; Ding S; Cheng W
Anal Chim Acta; 2019 Aug; 1067():129-136. PubMed ID: 31047144
[TBL] [Abstract][Full Text] [Related]
11. BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML).
Arana-Trejo RM; Ruíz Sánchez E; Ignacio-Ibarra G; Báez de la Fuente E; Garces O; Gómez Morales E; Castro Granados M; Ovilla Martínez R; Rubio-Borja ME; Solís Anaya L; Herrera P; Delgado Llamas J; Kofman S
Clin Lab Haematol; 2002 Jun; 24(3):145-50. PubMed ID: 12067277
[TBL] [Abstract][Full Text] [Related]
12. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia.
Lichty BD; Keating A; Callum J; Yee K; Croxford R; Corpus G; Nwachukwu B; Kim P; Guo J; Kamel-Reid S
Br J Haematol; 1998 Dec; 103(3):711-5. PubMed ID: 9858221
[TBL] [Abstract][Full Text] [Related]
13. [A multicenter comparison study on the detection of BCR-ABL tyrosine kinase domain point mutation].
Qin Y; Wang D; Qiao C; Shen H; Geng S; Cao Z; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):902-5. PubMed ID: 26632460
[TBL] [Abstract][Full Text] [Related]
14. [Detection and quantification of aberrant leukemia fusion gene by real-time RT-PCR].
Li XJ; Yu MJ; Liang Y; He D; Li B; Hu J; Chen Q; Li HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):969-73. PubMed ID: 19698240
[TBL] [Abstract][Full Text] [Related]
15. Frequency of BCR-ABL fusion transcripts in Sudanese patients with chronic myeloid leukemia using real-time reverse transcription-polymerase chain reaction.
Muddathir AM; Kordofani AA; Fadl-Elmula IM
Saudi Med J; 2013 Jan; 34(1):29-33. PubMed ID: 23299156
[TBL] [Abstract][Full Text] [Related]
16. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
[TBL] [Abstract][Full Text] [Related]
17. Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
Guo JQ; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus RB
Leukemia; 2002 Dec; 16(12):2447-53. PubMed ID: 12454751
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
20. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
